Helenalin-mediated post-transcriptional regulation of p21(Cip1) inhibits 3T3-L1 preadipocyte proliferation

Journal of Cellular Biochemistry

Volumn 105, Issue 3, 2008, Pages 913-921

  Fernandes, Karishma M ^a   Auld, Corinth A ^a   Hopkins, Robin G ^a   Morrison, Ron F ^a  

^a UNIVERSITY OF NORTH CAROLINA AT GREENSBORO   (United States)

Author keywords

Adipocyte; Cell cycle; Obesity; Proliferation

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1; F BOX PROTEIN; HELENALIN; MESSENGER RNA; PROTEASOME; PROTEIN P21;

ANIMAL CELL; ARTICLE; CELL CYCLE PROGRESSION; CELL PROLIFERATION; CELL STRAIN 3T3; CONTROLLED STUDY; GENETIC TRANSCRIPTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION;

3T3-L1 CELLS; ADIPOCYTES; ANIMALS; APOPTOSIS; CELL DIFFERENTIATION; CELL NUCLEUS; CELL PROLIFERATION; CYCLIN-DEPENDENT KINASE 2; CYCLIN-DEPENDENT KINASE INHIBITOR P21; G1 PHASE; GENE EXPRESSION REGULATION; MICE; SESQUITERPENES; STEM CELLS; UBIQUITINATION;

EID: 54849433139     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.21894     Document Type: Article

References (38)

1. Auld CA, Hopkins RG, Fernandes KM, Morrison RF. 2006. Novel effect of helenalin on Akt signaling and Skp2 expression in 3T3-L1 preadipocytes. Biochem Biophys Res Commun 346:314-320.
2. Auld CA, Fernandes KM, Morrison RF. 2007. Skp2-mediated p27(Kip1) degradation during S/G(2) phase progression of adipocyte hyperplasia. J Cell Physiol 211:101-111.
3. Basile JR, Eichten A, Zacny V, Munger K. 2003. NF-kappaB-mediated induction of p21(Cip1/Waf1) by tumor necrosis factor alpha induces growth arrest and cytoprotection in normal human keratinocytes. Mol Cancer Res 1:262-270.
4. Cayrol C, Ducommun B. 1998. Interaction with cyclin-dependent kinases and PCNA modulates proteasome-dependent degradation of p21. Oncogene 17:2437-2444.
5. Chang PY, Miyamoto S. 2006. Nuclear factor-kappaB dimer exchange promotes a p21(waf1/cip1) superinduction response in human T leukemic cells. Mol Cancer Res 4:101-112.
6. Cheng M, Olivier P, Diehl JA, Fero M, Roussel MF, Roberts JM, Sherr CJ. 1999. The p21(Cip1) and p27(Kip1) CDK 'inhibitors' are essential activators of cyclin D-dependent kinases in murine fibroblasts. EMBO J 18:1571-1583.
7. Coleman ML, Marshall CJ, Olson MF. 2003. Ras promotes p21(Waf1/Cip1) protein stability via a cyclin D1-imposed block in proteasome-mediated degradation. EMBO J 22:2036-2046.
8. Coqueret O. 2003. New roles for p21 and p27 cell-cycle inhibitors: A function for each cell compartment? Trends Cell Biol 13:65-70.
9. Dirsch VM, Stuppner H, Vollmar AM. 2001a. Cytotoxic sesquiterpene lactones mediate their death-inducing effect in leukemia T cells by triggering apoptosis. Planta Med 67:557-559.
10. Dirsch VM, Stuppner H, Vollmar AM. 2001b. Helenalin triggers a CD95 death receptor-independent apoptosis that is not affected by overexpression of Bclx-(L) or Bcl-2. Cancer Res 61:5817-5823.
11. Dotto GP. 2000. p21(WAF1/Cip1): More than a break to the cell cycle? Biochim Biophys Acta 1471:M43-M56.
12. El Deiry WS. 2001. Akt takes centre stage in cell-cycle deregulation. Nat Cell Biol 3:E71-E73.
13. Gertsch J, Sticher O, Schmidt T, Heilmann J. 2003. Influence of helenanolide-type sesquiterpene lactones on gene transcription profiles in Jurkat T cells and human peripheral blood cells: Anti-inflammatory and cytotoxic effects. Biochem Pharmacol 66:2141-2153.
14. Grippo AA, Hall IH, Kiyokawa H, Muraoka O, Shen YC, Lee KH. 1992. The cytotoxicity of helenalin, its mono and difunctional esters, and related sesquiterpene lactones in murine and human tumor cells. Drug Des Discov 8:191-206.
15. Hall IH, Lee KH, Mar EC, Starnes CO, Waddell TG. 1977. Antitumor agents. 21. A. proposed mechanism for inhibition of cancer growth by tenulin and helenalin and related cyclopentenones. J Med Chem 20:333-337.
16. Hall IH, Lee KH, Starnes CO, Eigebaly SA, Ibuka T, Wu YS, Kimura T, Haruna M. 1978. Antitumor agents XXX: Evaluation of alpha-methylene-gamma- lactone-containing agents for inhibition of tumor growth, respiration, and nucleic acid synthesis. J Pharm Sci 67:1235-1239.
17. Hausman DB, DiGirolamo M, Bartness TJ, Hausman GJ, Martin RJ. 2001. The biology of white adipocyte proliferation. Obes Rev 2:239-254.
18. Helt CE, Staversky RJ, Lee YJ, Bambara RA, Keng PC, O'Reilly MA. 2004. The Cdk and PCNA domains on p21Cip1 both function to inhibit G1/S progression during hyperoxia. Am J Physiol Lung Cell Mol Physiol 286:L506-L513.
19. Huang PR, Yeh YM, Wang TC. 2005. Potent inhibition of human telomerase by helenalin. Cancer Lett 227:169-174.
20. Jin Y, Lee H, Zeng SX, Dai MS, Lu H. 2003. MDM2 promotes p21waf1/cip1 proteasomal turnover independently of ubiquitylation. EMBO J 22:6365-6377.
21. LaBaer J, Garrett MD, Stevenson LF, Slingerland JM, Sandhu C, Chou HS, Fattaey A, Harlow E. 1997. New functional activities for the p21 family of CDK inhibitors. Genes Dev 11:847-862.
22. Lee KH, Hall IH, Mar EC, Starnes CO, ElGebaly SA, Waddell TG, HADGRAFT RI, Ruffner CG, Weidner I. 1977. Sesquiterpene antitumor agents: Inhibitors of cellular metabolism. Science 196:533-536.
23. Lyss G, Schmidt TJ, Merfort I, Pahl HL. 1997. Helenalin, an anti-inflammatory sesquiterpene lactone from Arnica, selectively inhibits transcription factor NF-kappaB. Biol Chem 378:951-961.
24. Lyss G, Knorre A, Schmidt TJ, Pahl HL, Merfort I. 1998. The antiinflammatory sesquiterpene lactone helenalin inhibits the transcription factor NF-kappaB by directly targeting p65. J Biol Chem 273:33508-33516.
25. Morrison RF, Farmer SR. 1999. Role of PPARgamma in regulating a cascade expression of cyclin-dependent kinase inhibitors, p18(INK4c) and p21(Waf1/Cip1), during adipogenesis. J Biol Chem 274:17088-17097.
26. Naaz A, Holsberger DR, Iwamoto GA, Nelson A, Kiyokawa H, Cooke PS. 2004. Loss of cyclin-dependent kinase inhibitors produces adipocyte hyperplasia and obesity. FASEB J 18:1925-1927.
27. Planas-Silva MD, Weinberg RA. 1997. Estrogen-dependent cyclin E-cdk2 activation through p21 redistribution. Mol Cell Biol 17:4059-4069.
28. Powis G, Gallegos A, Abraham RT, Ashendel CL, Zalkow LH, Grindey GB, Bonjouklian R. 1994. Increased intracellular Ca2R signaling caused by the antitumor agent helenalin and its analogues. Cancer Chemother Pharmacol 34:344-350.
29. Prins JB, O'Rahilly S. 1997. Regulation of adipose cell number in man. Clin Sci (Lond) 92:3-11.
30. Rousseau D, Cannella D, Boulaire J, Fitzgerald P, Fotedar A, Fotedar R. 1999. Growth inhibition by CDK-cyclin and PCNA binding domains of p21 occurs by distinct mechanisms and is regulated by ubiquitin-proteasome pathway. Oncogene 18:4313-4325.
31. Seitz CS, Deng H, Hinata K, Lin Q, Khavari PA. 2000. Nuclear factor kappaB subunits induce epithelial cell growth arrest. Cancer Res 60:4085-4092.
32. Sherr CJ, Roberts JM. 1999. CDK inhibitors: Positive and negative regulators of G1-phase progression. Genes Dev 13:1501-1512.
33. Sherr CJ, Roberts JM. 2004. Living with or without cyclins and cyclin-dependent kinases. Genes Dev 18:2699-2711.
34. Tang QQ, Otto TC, Lane MD. 2003a. CCAAT/enhancer-binding protein beta is required for mitotic clonal expansion during adipogenesis. Proc Natl Acad Sci 100:850-855.
35. Tang QQ, Otto TC, Lane MD. 2003b. Mitotic clonal expansion: A synchronous process required for adipogenesis. Proc Natl Acad Sci 100:44-49.
36. Touitou R, Richardson J, Bose S, Nakanishi M, Rivett J, Allday MJ. 2001. A degradation signal located in the C-terminus of p21WAF1/CIP1 is a binding site for the C8 alpha-subunit of the 20S proteasome. EMBO J 20:2367-2375.
37. Zhang H, Hannon GJ, Casso D, Beach D. 1994. p21 is a component of active cell cycle kinases. Cold Spring Harb Symp Quant Biol 59:21-29.
38. Zhang Z, Wang H, Li M, Agrawal S, Chen X, Zhang R. 2004. MDM2 is a negative regulator of p21WAF1/CIP1, independent of p53. J Biol Chem 279:16000-16006.